Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Cressey

Showing results (61-70 of 160) with videos related to

Pageof 16
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|November 16, 2011
Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartumTim R Cressey, Alice Stek, Edmund Capparelli, et al.
Antiviral Therapy|October 11, 2017
Pharmacokinetics of rilpivirine and 24-week outcomes after switching from efavirenz in virologically suppressed HIV-1-infected adolescentsWatsamon Jantarabenjakul, Suvaporn Anugulruengkitt, Naruporn Kasipong, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 2016
Optimization of the strength of the efavirenz/lamivudine/abacavir fixed-dose combination for paediatric patientsNaïm Bouazza, Tim R Cressey, Frantz Foissac, et al.
The Pediatric Infectious Disease Journal|May 18, 2016
Rilpivirine Pharmacokinetics Without and With Darunavir/Ritonavir Once Daily in Adolescents and Young AdultsMarc Foca, Ram Yogev, Andrew Wiznia, et al.
Pharmaceutics|October 26, 2024
Pharmacodynamics of Rivaroxaban and Dabigatran in Adults with Diffuse Large B-Cell Lymphoma Receiving R-CHOP ImmunochemotherapyTeerachat Punnachet, Tim R Cressey, Porntipa Apiwatnakorn, et al.
Viruses|August 28, 2021
Lack of Association between Adverse Pregnancy Outcomes and Zika Antibodies among Pregnant Women in Thailand between 1997 and 2015Nicole Ngo-Giang-Huong, Charline Leroi, Dahlene Fusco, et al.
The Pediatric Infectious Disease Journal|September 2, 2016
Pharmacokinetics of Unboosted Atazanavir in Treatment-experienced HIV-infected Children, Adolescents and Young AdultsTim R Cressey, Rohan Hazra, Andrew Wiznia, et al.
AIDS (London, England)|July 14, 2010
Pharmacokinetics and virologic response of zidovudine/lopinavir/ritonavir initiated during the third trimester of pregnancyTim R Cressey, Gonzague Jourdain, Boonsong Rawangban, et al.
Journal of the Pediatric Infectious Diseases Society|May 21, 2016
Pharmacokinetics of Once-Daily Darunavir/Ritonavir With and Without Etravirine in Human Immunodeficiency Virus-Infected Children, Adolescents, and Young AdultsKajal B Larson, Tim R Cressey, Ram Yogev, et al.
Journal of the Pediatric Infectious Diseases Society|April 23, 2016
Pharmacokinetics of Darunavir/Ritonavir With Etravirine Both Twice Daily in Human Immunodeficiency Virus-Infected Adolescents and Young AdultsTim R Cressey, Ram Yogev, Andrew Wiznia, et al.
Pageof 16

Showing results (61-70 of 160) with videos related to

Sort By:
Pageof 16
Journal of Acquired Immune Deficiency Syndromes (1999)|November 16, 2011
Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartumTim R Cressey, Alice Stek, Edmund Capparelli, et al.
Antiviral Therapy|October 11, 2017
Pharmacokinetics of rilpivirine and 24-week outcomes after switching from efavirenz in virologically suppressed HIV-1-infected adolescentsWatsamon Jantarabenjakul, Suvaporn Anugulruengkitt, Naruporn Kasipong, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 2016
Optimization of the strength of the efavirenz/lamivudine/abacavir fixed-dose combination for paediatric patientsNaïm Bouazza, Tim R Cressey, Frantz Foissac, et al.
The Pediatric Infectious Disease Journal|May 18, 2016
Rilpivirine Pharmacokinetics Without and With Darunavir/Ritonavir Once Daily in Adolescents and Young AdultsMarc Foca, Ram Yogev, Andrew Wiznia, et al.
Pharmaceutics|October 26, 2024
Pharmacodynamics of Rivaroxaban and Dabigatran in Adults with Diffuse Large B-Cell Lymphoma Receiving R-CHOP ImmunochemotherapyTeerachat Punnachet, Tim R Cressey, Porntipa Apiwatnakorn, et al.
Viruses|August 28, 2021
Lack of Association between Adverse Pregnancy Outcomes and Zika Antibodies among Pregnant Women in Thailand between 1997 and 2015Nicole Ngo-Giang-Huong, Charline Leroi, Dahlene Fusco, et al.
The Pediatric Infectious Disease Journal|September 2, 2016
Pharmacokinetics of Unboosted Atazanavir in Treatment-experienced HIV-infected Children, Adolescents and Young AdultsTim R Cressey, Rohan Hazra, Andrew Wiznia, et al.
AIDS (London, England)|July 14, 2010
Pharmacokinetics and virologic response of zidovudine/lopinavir/ritonavir initiated during the third trimester of pregnancyTim R Cressey, Gonzague Jourdain, Boonsong Rawangban, et al.
Journal of the Pediatric Infectious Diseases Society|May 21, 2016
Pharmacokinetics of Once-Daily Darunavir/Ritonavir With and Without Etravirine in Human Immunodeficiency Virus-Infected Children, Adolescents, and Young AdultsKajal B Larson, Tim R Cressey, Ram Yogev, et al.
Journal of the Pediatric Infectious Diseases Society|April 23, 2016
Pharmacokinetics of Darunavir/Ritonavir With Etravirine Both Twice Daily in Human Immunodeficiency Virus-Infected Adolescents and Young AdultsTim R Cressey, Ram Yogev, Andrew Wiznia, et al.
Pageof 16